|
Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study |
Reaney M, Cypryk K, Tentolouris N, Jecht M, Cleall S, Petzinger U, Koivisto V |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Reaney M, Cypryk K, Tentolouris N, Jecht M, Cleall S, Petzinger U, Koivisto V. Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study. Diabetes Research and Clinical Practice 2012; 97(2): 231-241 Indexing Status Subject indexing assigned by NLM MeSH Aged; Diabetes Mellitus, Type 2 /blood /drug therapy /economics; Europe; Female; Hemoglobin A, Glycosylated /metabolism; Humans; Hypoglycemic Agents /economics /therapeutic use; Insulin /analogs & Male; Middle Aged; Prospective Studies; Surveys and Questionnaires; derivatives /economics /therapeutic use AccessionNumber 22012033998 Date bibliographic record published 04/01/2013 |
|
|
|